{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:14:50Z","timestamp":1788455690985,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The protein Talin1 encoded by the\n                    <jats:italic>TLN1<\/jats:italic>\n                    gene is a focal adhesion-related protein that binds to various cytoskeletal proteins and plays an important role in cell adhesion and movement. Recent studies have shown that it is overexpressed in prostate cancer, liver cancer, and oral squamous cell carcinoma, and is closely related to tumor progression and metastasis. This study integrated bioinformatics and functional analysis to reveal the prognosis and potential functions of\n                    <jats:italic>TLN1<\/jats:italic>\n                    in AML. The results showed that the expression level of\n                    <jats:italic>TLN1<\/jats:italic>\n                    was abnormally increased in AML and localized in the cell membrane and cytoplasm, and\n                    <jats:italic>TLN1<\/jats:italic>\n                    is a significant prognostic indicator of overall survival (OS). Enrichment analysis of related genes showed that\n                    <jats:italic>TLN1<\/jats:italic>\n                    is related to neutrophil mediated immunity, neutrophil activation and may regulate important signal pathways in hematological tumors including tyrosine kinase receptor, FLT3 and PIK3\/AKT. The PPI network shows that\n                    <jats:italic>TLN1<\/jats:italic>\n                    and\n                    <jats:italic>MYH9<\/jats:italic>\n                    may be involved in the process of AML tumors together with\n                    <jats:italic>PIP5K1C, ROCK1, S100A4, MY01A<\/jats:italic>\n                    and\n                    <jats:italic>WAC<\/jats:italic>\n                    . Immune infiltration analysis explains that\n                    <jats:italic>TLN1<\/jats:italic>\n                    is associated with multiple immune cells and may be an important immune marker in AML. Furthermore, molecular biology experiments confirmed that\n                    <jats:italic>TLN1<\/jats:italic>\n                    is related to the proliferation, differentiation and cycle of AML cells. Silencing\n                    <jats:italic>TLN1<\/jats:italic>\n                    can inhibit the proliferation of AML cells and promote differentiation through the Talin1\/P-AKT\/CREB signaling pathway.\n                  <\/jats:p>","DOI":"10.1186\/s12885-022-10099-0","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:02:45Z","timestamp":1664431365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["RETRACTED ARTICLE: Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia"],"prefix":"10.1186","volume":"22","author":[{"given":"Di","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"23","key":"10099_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"10099_CR2","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD. Jemal a, Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10099_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3343\/alm.2019.39.3.311","volume":"39","author":"J Jung","year":"2019","unstructured":"Jung J, Cho BS, Kim HJ, et al. Reclassification of acute myeloid leukemia according to the 2016 WHO classification. Ann Lab Med. 2019;39(3):311\u20136.","journal-title":"Ann Lab Med"},{"issue":"9865","key":"10099_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","volume":"381","author":"F Ferrara","year":"2013","unstructured":"Ferrara F. Schiffer C a, acute myeloid leukaemia in adults. Lancet. 2013;381(9865):484\u201395.","journal-title":"Lancet"},{"key":"10099_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/738137","volume":"2011","author":"PH Vachon","year":"2011","unstructured":"Vachon PH. Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduction. 2011;2011:738137.","journal-title":"J Signal Transduction"},{"issue":"1","key":"10099_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2006.10.048","volume":"128","author":"KL Wegener","year":"2007","unstructured":"Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by Talin. Cell. 2007;128(1):171\u201382.","journal-title":"Cell"},{"issue":"11","key":"10099_CR7","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1083\/jcb.201808061","volume":"217","author":"BT Goult","year":"2018","unstructured":"Goult BT, Yan J. Schwartz M a, Talin as a mechanosensitive signaling hub. J Cell Biol. 2018;217(11):3776\u201384.","journal-title":"J Cell Biol"},{"issue":"8","key":"10099_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-13-0082","volume":"19","author":"SM Singel","year":"2013","unstructured":"Singel SM, Cornelius C, Batten K, et al. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013;19(8):2061\u201370.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"4","key":"10099_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"43","key":"10099_CR10","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10099_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"key":"10099_CR12","doi-asserted-by":"crossref","unstructured":"Warde-Farley D,Donaldson S L,Comes O, et al, The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010;38 (Web Server issue), W214-20.","DOI":"10.1093\/nar\/gkq537"},{"issue":"D1","key":"10099_CR13","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u2013d963.","journal-title":"Nucleic Acids Res"},{"key":"10099_CR14","doi-asserted-by":"crossref","unstructured":"Lim IR, Joo HJ, Jeong M, et al. Talin modulation by a synthetic N-Acylurea derivative reduces angiogenesis in human endothelial cells. Int J Mol Sci. 2017;18(1):221.","DOI":"10.3390\/ijms18010221"},{"issue":"4","key":"10099_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/leu.2015.332","volume":"30","author":"M Mart\u00ednez-Moreno","year":"2016","unstructured":"Mart\u00ednez-Moreno M, Leiva M, Aguilera-Montilla N, et al. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by \u03b14\u03b21 cytoplasmic-binding proteins. Leukemia. 2016;30(4):861\u201372.","journal-title":"Leukemia"},{"issue":"8","key":"10099_CR16","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1080\/10428194.2017.1406089","volume":"59","author":"A Halder","year":"2018","unstructured":"Halder A, Nayak KB. Chakraborty S, Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia. Leukemia Lymphoma. 2018;59(8):2008\u201310.","journal-title":"Leukemia Lymphoma"},{"issue":"13","key":"10099_CR17","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.7150\/ijms.46234","volume":"17","author":"B Yang","year":"2020","unstructured":"Yang B, Liu H, Bi Y, et al. MYH9 promotes cell metastasis via inducing angiogenesis and epithelial Mesenchymal transition in esophageal squamous cell carcinoma. Int J Med Sci. 2020;17(13):2013\u201323.","journal-title":"Int J Med Sci"},{"key":"10099_CR18","doi-asserted-by":"crossref","unstructured":"Betapudi V,Licate L S.Egelhoff T T, Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. Cancer Res.\u00a02006;66(9):4725-4733.","DOI":"10.1158\/0008-5472.CAN-05-4236"},{"issue":"2","key":"10099_CR19","first-page":"1049","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu L, Yi J, Deng X, et al. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer. Oncol Lett. 2019;18(2):1049\u201356.","journal-title":"Oncol Lett"},{"issue":"1","key":"10099_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.18632\/oncotarget.10613","volume":"8","author":"M Yu","year":"2017","unstructured":"Yu M, Wang J, Zhu Z, et al. Prognostic impact of MYH9 expression on patients with acute myeloid leukemia. Oncotarget. 2017;8(1):156\u201363.","journal-title":"Oncotarget"},{"issue":"1","key":"10099_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41392-020-0111-4","volume":"5","author":"X Lin","year":"2020","unstructured":"Lin X, Li AM, Li YH, et al. Silencing MYH9 blocks HBx-induced GSK3\u03b2 ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Signal Transduction Targeted Therapy. 2020;5(1):13.","journal-title":"Signal Transduction Targeted Therapy"},{"issue":"8","key":"10099_CR22","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","volume":"15","author":"KM Sakamoto","year":"2009","unstructured":"Sakamoto KM. Frank D a, CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res. 2009;15(8):2583\u20137.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10099_CR23","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/cncr.21401","volume":"104","author":"DB Shankar","year":"2005","unstructured":"Shankar DB, Cheng JC. Sakamoto K M, role of cyclic AMP response element binding protein in human leukemias. Cancer. 2005;104(9):1819\u201324.","journal-title":"Cancer"},{"issue":"43","key":"10099_CR24","doi-asserted-by":"publisher","first-page":"15605","DOI":"10.1073\/pnas.0507679102","volume":"102","author":"A Stepulak","year":"2005","unstructured":"Stepulak A, Sifringer M, Rzeski W, et al. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci U S A. 2005;102(43):15605\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10099_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrm3624","volume":"14","author":"DA Calderwood","year":"2013","unstructured":"Calderwood DA, Campbell ID. Critchley D R, Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol. 2013;14(8):503\u201317.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10099_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jsb.2013.05.014","volume":"184","author":"BT Goult","year":"2013","unstructured":"Goult BT, Xu XP, Gingras AR, et al. Structural studies on full-length talin1 reveal a compact auto-inhibited dimer: implications for Talin activation. J Struct Biol. 2013;184(1):21\u201332.","journal-title":"J Struct Biol"},{"issue":"1","key":"10099_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2019.08.034","volume":"179","author":"D Dedden","year":"2019","unstructured":"Dedden D, Schumacher S, Kelley CF, et al. The architecture of Talin1 reveals an autoinhibition mechanism. Cell. 2019;179(1):120\u2013131.e13.","journal-title":"Cell"},{"issue":"18","key":"10099_CR28","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.cub.2013.07.054","volume":"23","author":"SJ Ellis","year":"2013","unstructured":"Ellis SJ, Goult BT, Fairchild MJ, et al. Talin autoinhibition is required for morphogenesis. Curr Biol. 2013;23(18):1825\u201333.","journal-title":"Curr Biol"}],"updated-by":[{"DOI":"10.1186\/s12885-026-16870-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10099-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10099-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10099-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:16:43Z","timestamp":1788452203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-022-10099-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10099"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10099-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-026-16870-x","URL":"https:\/\/doi.org\/10.1186\/s12885-026-16870-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted under the approval of the Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the Ethics Committee. All patients and\/or legal guardians were informed prior to experiments and signed written informed consents.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1027"}}